Clinical Trial Update: Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Ahmed Valve glaucoma implant with adjunctive subconjunctival bevacizumab for refractory glaucoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Ahmed Valve Glaucoma Implant
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Vanak Eye Surgery Center | Conditions: Refractory Glaucoma | Phase 3 | Status: UNKNOWN